Determination of the SARS-CoV-2/COVID-19 seroprevalence of patients in emergency rooms at the university hospitals in North Rhine-Westphalia
- Conditions
- Seroprevalence of SARS-CoV-2 antibodies in emergency room patients
- Registration Number
- DRKS00029414
- Lead Sponsor
- Institut für Virologie Uniklinik Köln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Age =18 years
- Study participants are patients in the emergency room of the university hospital
- According to the medical assessment, the information provided and the additional blood collection do not represent any additional burden for the study participants.
- Ability to consent and consent to participate in the study.
- The ability to consent is checked according to a medical assessment, also with a special focus on the medication, possible pain and the exceptional emotional situation of the patient in an emergency situation and the resulting pressure situation.
Exclusion Criteria
- <8 weeks (males) or <12 weeks (females) since last blood volume draw of =500 mL
- Inability to give consent
- Age <18 years
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of SARS-CoV-2 antibodies in patients in emergency departments at university hospitals in August 2022
- Secondary Outcome Measures
Name Time Method Evaluation of nucleocapsid antibodies for the detection of a past SARS-Cov-2 infections